Ensign Ownership
ENSG Stock | USD 129.59 1.20 0.92% |
Shares in Circulation | First Issued 2005-03-31 | Previous Quarter 58.4 M | Current Value 58.6 M | Avarage Shares Outstanding 47.7 M | Quarterly Volatility 8.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Ensign |
Ensign Stock Ownership Analysis
About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Ensign was currently reported as 32.23. The company has Price/Earnings To Growth (PEG) ratio of 1.38. Ensign Group recorded earning per share (EPS) of 5.12. The entity last dividend was issued on the 31st of December 2024. The firm had 1069:1000 split on the 1st of October 2019. The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company was incorporated in 1999 and is based in San Juan Capistrano, California. Ensign operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 25900 people. To learn more about The Ensign Group call Christopher Christensen at 949 487 9500 or check out https://ensigngroup.net.Besides selling stocks to institutional investors, Ensign also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ensign's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ensign's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Ensign Quarterly Liabilities And Stockholders Equity |
|
Ensign Insider Trades History
Roughly 3.0% of The Ensign Group are currently held by insiders. Unlike Ensign's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ensign's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ensign's insider trades
Ensign Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ensign is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading The Ensign Group backward and forwards among themselves. Ensign's institutional investor refers to the entity that pools money to purchase Ensign's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Copeland Capital Management, Llc | 2024-12-31 | 944.1 K | Northern Trust Corp | 2024-12-31 | 937.9 K | Charles Schwab Investment Management Inc | 2024-12-31 | 787.1 K | Goldman Sachs Group Inc | 2024-12-31 | 723.8 K | Van Berkom And Associates Inc | 2024-12-31 | 701 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 696.1 K | T. Rowe Price Investment Management,inc. | 2024-12-31 | 686.5 K | Norges Bank | 2024-12-31 | 683 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 641.5 K | Blackrock Inc | 2024-12-31 | 7.1 M | Vanguard Group Inc | 2024-12-31 | 6.2 M |
Ensign Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ensign insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ensign's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ensign insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ensign Outstanding Bonds
Ensign issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ensign Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ensign bonds can be classified according to their maturity, which is the date when The Ensign Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ENQLN 11625 01 NOV 27 Corp BondUS29357JAC09 | View | |
US29355AAK34 Corp BondUS29355AAK34 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Enpro Industries 575 Corp BondUS29355XAG25 | View | |
ESGR 31 01 SEP 31 Corp BondUS29359UAC36 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Ensign Corporate Filings
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 5th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F3 | 20th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Ensign Group is a strong investment it is important to analyze Ensign's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ensign's future performance. For an informed investment choice regarding Ensign Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in The Ensign Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensign. If investors know Ensign will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensign listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.645 | Dividend Share 0.243 | Earnings Share 5.12 | Revenue Per Share | Quarterly Revenue Growth 0.155 |
The market value of Ensign Group is measured differently than its book value, which is the value of Ensign that is recorded on the company's balance sheet. Investors also form their own opinion of Ensign's value that differs from its market value or its book value, called intrinsic value, which is Ensign's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensign's market value can be influenced by many factors that don't directly affect Ensign's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensign's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensign is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensign's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.